Sharps technology announces closing of $3.8 million private placement priced at-the-market

New york, feb. 06, 2023 (globe newswire) -- sharps technology, inc. (the “company”, "sharps") (nasdaq: “stss” and “stssw”), an innovative medical device and drug delivery company offering patented, best-in-class syringe products, today announced that it closed its previously announced private placement pursuant to a securities purchase agreement with institutional investors on february 3, 2023. the aggregate gross proceeds of the private placement were approximately $3.8 million priced at the market under nasdaq rules. proceeds will help support the manufacturing of pre-filled specialty syringe systems through its partnership with nephron pharmaceuticals.
STSS Ratings Summary
STSS Quant Ranking